Successfully navigating the complexities of today’s biologics demands is complicated. Discover insights from a recent industry roundtable discussion, during which industry experts gathered to share their experiences dealing with these powerful drugs. From overcoming the current challenges resulting from the COVID-19 pandemic to clearing common hurdles in CMC partnerships, panelists share their strategies for moving forward, including what to look for in an optimal CDMO partner.
Don’t miss your free insights from Scrip, presented in partnership with PCI Pharma Services. Download your free ““Biologics Development, Manufacturing & Packaging Roundtable” report.